📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

BACPHARPharmaceuticals

Bacil Pharma Ltd — Financial Ratios & Key Metrics

₹47.73

-1.10%

P/E Ratio93.40xIndustry: 31.77x

ROE-0.98%Return on equity

ROCE-0.97%Return on capital

Debt/Equity0.00Debt free ✓

💎

Valuation & Profitability

P/E Ratio

93.40x

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹59.78 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

2.13%

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+20.55%

3 Months

+18.80%

6 Months

+0.24%

1 Year

-9.55%

52W Low

₹27

Current

₹48

52W High

₹52

83% of 52-week range — Near highs

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹45

▲ Price above SMA 50 — Bullish

SMA 200

₹41

▲ Long-term uptrend

Volume Signal

442% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Bacil Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.